IL-17 induces the expression of some chemokines and cytokines including IL-6 and TGF-β, in a variety of cell types, including the BMSCs [43, 44], implying that the correlation between IL-6, TGF-β, and IL-17 is responsible for the progression of myeloma. This evidence concerns the gene TGFB1 and plasma cell myeloma.